RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 109 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q3 2015. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $205,000 | +253.4% | 22,877 | +112.3% | 0.00% | – |
| Q2 2016 | $58,000 | -96.6% | 10,778 | -96.7% | 0.00% | – |
| Q4 2015 | $1,689,000 | -79.0% | 324,786 | -75.6% | 0.00% | -100.0% |
| Q3 2015 | $8,053,000 | +1027.9% | 1,331,128 | +2841.8% | 0.00% | – |
| Q2 2015 | $714,000 | +803.8% | 45,249 | +502.0% | 0.00% | – |
| Q4 2014 | $79,000 | -76.3% | 7,516 | -78.4% | 0.00% | – |
| Q3 2014 | $334,000 | -50.4% | 34,841 | -40.3% | 0.00% | – |
| Q2 2014 | $674,000 | +11.6% | 58,375 | -3.3% | 0.00% | – |
| Q1 2014 | $604,000 | +158.1% | 60,390 | +235.9% | 0.00% | – |
| Q4 2013 | $234,000 | +290.0% | 17,979 | +352.1% | 0.00% | – |
| Q3 2013 | $60,000 | +1.7% | 3,977 | -37.4% | 0.00% | – |
| Q2 2013 | $59,000 | – | 6,350 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 7,000,000 | $32,200,000 | 3.11% |
| SV Health Investors, LLC | 888,132 | $4,085,000 | 3.05% |
| Sarissa Capital Management LP | 2,725,000 | $12,535,000 | 2.76% |
| GREAT POINT PARTNERS LLC | 1,346,344 | $6,193,000 | 2.22% |
| Virtus ETF Advisers LLC | 126,869 | $584,000 | 0.80% |
| SPHERA FUNDS MANAGEMENT LTD. | 400,000 | $1,840,000 | 0.40% |
| TFS CAPITAL LLC | 459,546 | $2,114,000 | 0.30% |
| GLOBEFLEX CAPITAL L P | 238,239 | $1,096,000 | 0.29% |
| TURNER INVESTMENTS LLC | 161,100 | $741,000 | 0.20% |
| Birchview Capital, LP | 40,000 | $184,000 | 0.13% |